New hope for leukemia patients who have run out of options
NCT ID NCT07245251
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new drug called STR-P004 in 11 adults with a type of leukemia (ALL) that has come back or not responded to standard treatments. The main goals are to check if the drug is safe, find the right dose, and see if it helps fight the cancer. Participants will receive multiple doses and be closely monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBKASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.